Drug reference

inotersen

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 701

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(in-oh-ter′sen) Tegsedi

PDF page 701

Functional class

Func. class.: Metabolic agent

PDF page 701

Uses

USES: Polyneuropathy of hereditary transthyre- tin mediated amyloidosis

PDF page 701

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity to inotersen or any com- ponent; platelet count <100,000/mm3; history of acute glomerulonephritis caused by inotersen

PDF page 701

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult: SUBCUT 284 mg once weekly

PDF page 701

Available forms

Available forms: Prefilled syringe solu- tion for injection 284 mg/1.5 mL HIGH ALERT I

PDF page 701

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.

Drug reference

inotersen

Mosby’s 2024 Nursing Drug Reference

Source: Mosby’s 2024 Nursing Drug Reference
PDF pages: 701

Review source pages for extracted sections and age labels.

Overview

Names and pronunciation

(in-oh-ter′sen) Tegsedi

PDF page 701

Functional class

Func. class.: Metabolic agent

PDF page 701

Uses

USES: Polyneuropathy of hereditary transthyre- tin mediated amyloidosis

PDF page 701

Safety

Contraindications

CONTRAINDICATIONS Hypersensitivity to inotersen or any com- ponent; platelet count <100,000/mm3; history of acute glomerulonephritis caused by inotersen

PDF page 701

Dose and formulations

Dosage and routes

DOSAGE AND ROUTES Adult: SUBCUT 284 mg once weekly

PDF page 701

Available forms

Available forms: Prefilled syringe solu- tion for injection 284 mg/1.5 mL HIGH ALERT I

PDF page 701

Age labels are extracted for navigation. Check the complete source section and current local guidance before clinical use.